大型抑郁症治疗psilocybin:随机对照研究的系统审查
Li-Juan Li1, Yu Mo2, Zhan-Ming Shi3
1Department of Neurology, The First Affiliated Hospital of Hainan Medical University, Haikou, China.
Frontiers in psychiatry
|October 8, 2024
概括
псилоцибин在治疗主要抑郁症 (MDD) 方面表现有前途,有效改善成人抑郁和焦虑症状. 需要进一步的大规模试验来确认长期的疗效和安全性.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 重度抑郁症 (MDD) 是一种普遍且使人虚弱的心理健康状况.
- 目前用于MDD的治疗方法在某些患者的疗效和耐受性方面存在局限性.
- 正在研究MDD的新型治疗方法.
研究的目的:
- 系统地审查随机对照试验 (RCT),评估MDD的psilocybin.
- 评估psilocybin在患有MDD的成年患者中的有效性,安全性和耐受性.
- 综合证据证实了psilocybin对抑郁症状,焦虑和自杀念头的影响.
主要方法:
- 对RCT进行系统的文献搜索,截至2023年9月14日.
- 包括研究的主要结局是抑郁症状的变化.
- 提取关于疗效,安全性,耐受性和药物不良反应 (ADR) 的数据.
主要成果:
- 包括5项涉及472名患者的RCT;60%的研究表明, псилоцибин对MDD有有益影响.
- 与对照组相比,Psilocybin在80%的RCT中显著改善了焦虑症状.
- 在psilocybin和对照组之间,药物不良反应是可比的,头痛是最常见的.
结论:
- 西在改善MDD患者的抑郁和焦虑症状方面表现出有效性.
- 这项研究强调了西作为MDD治疗的潜力.
- 需要进一步的大规模RCT来确定长期的疗效和安全性.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
200
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
200
01:27Depressive Disorders: MDD and Dysthymia
65
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
65
01:18Depression: Overview
224
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
224
01:27Diagnostic and Statistical Manual of Mental Disorders (DSM)
48
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
48
01:30Electroconvulsive Therapy
28
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
28
01:25Antidepressant Drugs: Overview
375
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
375